Skip to main content
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: Contemp Clin Trials. 2013 Sep 19;36(2):10.1016/j.cct.2013.09.004. doi: 10.1016/j.cct.2013.09.004

Table 3.

Protocol Definition of a Pulmonary Exacerbation

The presence of a protocol-defined pulmonary exacerbation is defined by the following: One of the major criteria alone or Two of the minor signs/symptoms and fulfillment of symptom duration
Major Criteria: (One finding alone establishes the presence of a pulmonary exacerbation)
    (1) Absolute decrease in FEV1 (L) of ≥ 10% from best baseline at study initiation using office spirometry, unresponsive to albuterol (in participants able to reproducibly perform spirometry)
    (2)Oxygen saturation <90% on room air or absolute decrease of ≥ 5% from previous baseline
    (3) New lobar infiltrate(s) or atelectasi(e)s on chest radiograph
    (4) Hemoptysis (more than streaks on more than one occasion in past week)
Minor Signs/Symptoms: (Two minor signs/symptoms are required with duration criteria in the absence of major criteria)
    (1) Increased work of breathing or respiratory rate
    (2) New or increased adventitial sounds on lung exam
    (3) Weight loss ≥5% of body weight or decrease across 1 major percentile in weight percentile for age in past 6 months
    (4) Increased cough
    (5) Decreased exercise tolerance or level of activity
    (6) Increased chest congestion or change in sputum
Sign/Symptom Duration: (Required with two minor signs/symptoms in absence of major criteria): Initial sign or symptom present for ≥ 3 days
    Duration of sign/symptoms ≥3 days